Coe, F, Misra, V, McCabe, Y, Adderley, H, Woodhouse, L, Ayub, Z, Wang, X, Howell, S & Ekholm, M 2022, ' Average duration of prior treatment lines predicts clinical benefit to eribulin chemotherapy in patients with metastatic breast cancer ', Breast Cancer Research and Treatment, vol. 191, no. 3, pp. 535-543 . https://doi.org/10.1007/s10549-021-06438-7
kConFab Investigators, Polish Hereditary Breast Cancer Consortium & The Hereditary Breast Cancer Clinical Study Group 2021, ' Survival from breast cancer in women with a BRCA2 mutation by treatment ', British Journal of Cancer . https://doi.org/10.1038/s41416-020-01164-1